Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2024-05-21 00:00:00 ET · period of report 2024-05-17 · accession 0000914475-24-000129 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-21 | 2024-05-17 | NBIX | LYONS GARY A | Dir | M - OptEx | $0.00 | +2,100 | 119.0K | +2% | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | LYONS GARY A | Dir | M - OptEx | $0.00 | -2,100 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-17 | M | A | 2,100 | $0.00 | 119,047 | D | — | — | (F1) 110,964 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power. |
| 2 | Derivative | Restricted Stock Unit | 2024-05-17 | M | D | 2,100 | $0.00 | 0 | D | — · — to — | 2,100 Common Stock | (F2) Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. (F3) This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested. |